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Ghrelin is an octanoylated peptide hormone, produced by endocrine cells of the stomach,
which acts in the brain to increase food intake and body weight. Our understanding of the
mechanisms underlying ghrelin’s effects on eating behaviors has been greatly improved
by the generation and study of several genetically manipulated mouse models. These
models include mice overexpressing ghrelin and also mice with genetic deletion of ghrelin,
the ghrelin receptor [the growth hormone secretagogue receptor (GHSR)] or the enzyme
that post-translationally modifies ghrelin [ghrelin O-acyltransferase (GOAT)]. In addition,
a GHSR-null mouse model in which GHSR transcription is globally blocked but can be
cell-specifically reactivated in a Cre recombinase-mediated fashion has been generated.
Here, we summarize findings obtained with these genetically manipulated mice, with the
aim to highlight the significance of the ghrelin system in the regulation of both homeostatic
and hedonic eating, including that occurring in the setting of chronic psychosocial stress.
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INTRODUCTION
Ghrelin is a 28-amino acid octanoylated peptide hormone
secreted predominantly from a distinct population of endocrine
“ghrelin” cells located within the gastric oxyntic mucosa, pre-
viously referred to as P/D1-type cells in humans and A like-
type cells in rodents (Kojima and Kangawa, 2010). Ghrelin is
the only known naturally occurring peptide to be modified by
Ser3 O-octanoylation, a reaction catalyzed by the enzyme ghre-
lin O-acyl transferase (GOAT) (Yang et al., 2008; Kojima and
Kangawa, 2010). This post-translational modification is essen-
tial for the binding of ghrelin to and subsequently activation of
its specific receptor, the growth hormone secretagogue receptor
type 1a (GHSR). GHSR is a 7 transmembrane protein coupled
to the Gq subfamily of heterotrimeric GTP-binding proteins that
activates phospholipase C and in turn, induces release of cal-
cium from intracellular stores (Howard et al., 1996; Damian
et al., 2012). Stimulation of other signal transduction cascades
also have been demonstrated upon activation of GHSR, although
much of that data was characterized using transfected cell systems
(Cruz and Smith, 2008). GHSR is expressed in several regions of
the central nervous system and some peripheral organs (Cruz and
Smith, 2008).
Ghrelin’s actions are diverse. Ghrelin is a potent growth hor-
mone (GH) secretagogue and orexigenic peptide (Kojima and
Kangawa, 2010). Ghrelin also prevents falls in blood glucose
upon extreme caloric restriction and minimizes depressive-like
behavior upon chronic psychosocial stress (Lutter et al., 2008;
Goldstein et al., 2011). Moreover, ghrelin stimulates motor activ-
ity in the gastrointestinal tract and accelerates gastric emptying
(Peeters, 2003). Although desacyl-ghrelin, the non-octanoylated
form, does not bind to GHSR, some studies report that it can
modify certain physiological responses, including food intake and
glucose homeostasis (Delhanty et al., 2012).
Genetically-modified mouse models have been instrumental
in dissecting out the physiological roles of ghrelin, as well as the
specific sites of ghrelin action. Genetic modifications in mice can
be grouped in two classes: (1) Standard transgenic models, in
which a foreign DNA construct is randomly integrated into the
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mouse genome (commonly used for overexpression models) and
(2) Gene-targeted transgenic models, in which a gene disruption
or manipulation is introduced in a single gene via homologous
recombination between the foreign DNA and the endogenous
gene (commonly used for “knockout” and “knock-in” models)
(Davey and Maclean, 2006). In this review, we discuss ghre-
lin’s action on eating behaviors as determined using mice with
genetic manipulations in the ghrelin signaling system (Tables 1
and 2). We first focus on the role of ghrelin in homeostatic
eating and subsequently discuss the role of ghrelin in hedonic
eating.
GHRELIN AND HOMEOSTATIC EATING
Homeostatic eating is defined as food intake driven by neces-
sity, due to energy deficiency as perceived by the brain and
body. Ghrelin is the only known circulating peptide hormone
Table 1 | Studies of homeostatic eating behaviors in mouse models with genetic alterations in ghrelin-signaling system.
Model Summary References
Ghrelin overexpression (driven by
various promoters)
Elevated desacyl-ghrelin levels with conflicting food intake and body
weight results
Ariyasu et al., 2005; Asakawa et al.,
2005; Iwakura et al., 2005; Wei et al.,
2006; Zhang et al., 2008
Elevated ghrelin levels with no change in food intake (Reed et al.) or
increase in food intake (Bewick et al.)
Reed et al., 2008; Bewick et al., 2009
Ghrelin overexpression (SV40
T-antigen)
Increased ghrelin levels, with food intake and body weights
indistinguishable from wild-type littermates; Older transgenic mice
lose weight, likely due to large gastric tumors
Iwakura et al., 2009; Zhao et al., 2010b
Ghrelin analog overexpression Increase of ghrelin-like activity, no change in food intake, body
weight, energy expenditure or fat mass
Matsumoto et al., 2001; Yamada et al.,
2010; Ariyasu et al., 2012
Human ghrelin and GOAT
overexpression
Elevated human ghrelin only when fed diet containing medium-chain
triglycerides. No change in food intake but increase in body weight
Kirchner et al., 2009
Ghrelin knockout No changes in eating behaviors under CHD. Inconsistent results in
HFD feeding studies
Sun et al., 2003; Wortley et al., 2004,
2005; De Smet et al., 2006; Dezaki
et al., 2006; Pfluger et al., 2008; Sato
et al., 2008
GHSR knockout Attenuated anticipatory locomotor response.
Similar food intake, but subtle decrease in body weight under CHD
feeding
Sun et al., 2004, 2008; Abizaid et al.,
2006; Blum et al., 2009; Lin et al.,
2011; Ma et al., 2011
GHSR null (removable
transcriptional blocking cassette)
Female mice on CHD weigh less than wild-type controls. Consume
less food and are resistant to HFD-induced body weight gain upon
early HFD exposure
Zigman et al., 2005; Perello et al.,
2012
Ghrelin and GHSR knockout Lower body weight, but no change in food intake Pfluger et al., 2008
Site-selective GHSR Expression
(GHSR null crossed with
cell-specific Cre)
TH-promoter driven Cre: partially restores ghrelin-stimulated food
intake Phox2b-promoter driven Cre: lack ghrelin-induced food intake
Chuang et al., 2011; Scott et al., 2012
GHSR overexpression in GHRH
neurons
Increase in post-weaning growth rate. Increase in growth rate not
maintained in adulthood. No change in body weight on HFD,
although fat pad mass trended lower. Possible increase in HFD
intake
Lall et al., 2004
GOAT deficiency Normal body weight and fat mass under CHD feeding. Increase in
food intake but lower body weights under medium-chain triglyceride
rich diet
Gutierrez et al., 2008; Kirchner et al.,
2009; Zhao et al., 2010a
Ghrelin knockout (Ob/Ob
background)
Similar food intake and a modest increase in body weight as
compared to ob/ob mice
Sun et al., 2006
GHSR knockout (Ob/Ob
background)
Similar food intake and body weights to ob/ob mice Ma et al., 2012
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Table 2 | Studies of hedonic eating behaviors in mouse models with genetic alterations in ghrelin-signaling system.
Model References
GHSR knockout Suppressed intake of rewarding food in a free choice
(CHD/rewarding food) paradigm
Blum et al., 2009; Egecioglu et al.,
2010; Disse et al., 2011; Verhagen
et al., 2011; Lamont et al., 2012
GHSR null Lack cue potentiated feeding behavior. Do demonstrate CPP for
HFD post-CSDS. Fail to increase intake of CHD in response to
chronic stress
Perello et al., 2010; Chuang et al.,
2011; Walker et al., 2012
Site-selective GHSR expression
(GHSR null crossed with
cell-specific Cre)
TH-promoter driven Cre: sufficient to restore CSDS-induced CPP
for HFD
Chuang et al., 2011
GOAT deficiency Attenuated motivation for food in an operant responding model.
Decreased hedonic feeding response as examined in a “dessert
effect” protocol
Davis et al., 2012
that stimulates food intake (Cummings, 2006). Ghrelin trig-
gers eating even at times of minimal spontaneous food intake,
and its orexigenic actions are rapid, short-lived and potent
(Nakazato et al., 2001; Wren et al., 2001; Cummings, 2006). It
has been suggested that ghrelin is a physiologic meal initiator,
since its levels increase preprandially and decrease post-prandially
(Cummings et al., 2001). Ghrelin levels, in individuals under
restricted feeding schedules, increase approximately 1 h prior to
food presentation. In animals, this preprandial rise in ghrelin
occurs simultaneously or possibly precedes the increased locomo-
tion in anticipation of a scheduled meal (Drazen et al., 2006).
Indeed, ghrelin administration increases locomotor activity in
rats and foraging-like activities in hamsters (Keen-Rhinehart
and Bartness, 2005; Jerlhag et al., 2007). Thus, Blum et al.
hypothesized that ghrelin is secreted in anticipation of a meal
and correlates with anticipatory locomotor activity (Blum et al.,
2009).
Themechanism for ghrelin’s action on stimulating food intake
was initially thought to be through homeostatic hypothala-
mic circuits originating in the arcuate nucleus (ARC) (Willesen
et al., 1999; Nakazato et al., 2001; Kageyama et al., 2010). The
expression of GHSR, the only known receptor for ghrelin, has
been confirmed within the ARC by many techniques, includ-
ing in situ hybridization histochemistry, RT-PCR, immunohis-
tochemistry and Western blot analysis (Howard et al., 1996;
Guan et al., 1997; Willesen et al., 1999; Zigman et al., 2006).
Several studies have demonstrated that ghrelin has the capac-
ity to bind its receptor on arcuate NPY/AgRP neurons, resulting
in their activation and ensuing orexigenic behaviors (Willesen
et al., 1999; Nakazato et al., 2001; Wren et al., 2001; Kageyama
et al., 2010; Schaeffer et al., 2013). Interaction of ghrelin with
several other neuronal subtypes and brain sites also has been
shown to increase intake of freely-available food. These include,
among others, orexin-producing neurons of the lateral hypotha-
lamus (Olszewski et al., 2003; Toshinai et al., 2003). Additionally,
some evidence indicates that vagus nerve integrity is required
for ghrelin-induced food intake as well (Date et al., 2002; Date,
2012).
HOMEOSTATIC EATING IN MICE OVER EXPRESSING GHRELIN
In order to confirm the effects of ghrelin on homeostatic eat-
ing, several groups have attempted to produce transgenic mice
with chronically elevated ghrelin. These initial transgenes con-
tained the ghrelin gene driven by various promoters—including
those for CAG (Ariyasu et al., 2005; Asakawa et al., 2005), rat
insulin II (Iwakura et al., 2005), rat glucagon (Iwakura et al.,
2005), CMV (Wei et al., 2006) and FABP4 (Zhang et al., 2008)—
resulting in elevated ghrelin gene expression mainly in cell types
in which ghrelin gene expression does not usually occur. These
mouse models resulted in elevated desacyl-ghrelin rather than
elevations of ghrelin, presumably because this overexpression of
the ghrelin gene was targeted mostly to tissues lacking the ghrelin-
acylating enzyme, GOAT. Indeed, GOAT was not discovered until
2008. Most mouse models overproducing desacyl-ghrelin exhib-
ited similar food intake and body weight as compared to wild-
type mice (Iwakura et al., 2005; Wei et al., 2006); nonetheless,
some studies found reduced body weight, fat mass, nose-to-anus
length and/or food intake in their transgenic mice overexpressing
desacyl-ghrelin (Ariyasu et al., 2005; Asakawa et al., 2005; Zhang
et al., 2008). These findings may suggest that desacyl-ghrelin has
metabolic effects opposite to those of ghrelin.
Two groups successfully produced standard transgenic mice
with ghrelin overexpression. Reed et al. generated a transgenic
mouse model overexpressing ghrelin in neurons by using a
neuron-specific enolase promoter. These mice showed increased
ghrelin expression in brain and increased circulating ghrelin (∼5-
fold), although they did not differ from wild-type controls in
body weight, food intake, energy expenditure or fat mass (Reed
et al., 2008). Likewise, Bewick et al. generated a transgenic mouse
model overexpressing ghrelin, using a bacterial artificial chromo-
some containing the ghrelin gene and its promoter (Bewick et al.,
2009). These mice exhibited increased circulating ghrelin (∼1.5-
fold) and increased food intake without long-term body weight
gain, perhaps due to a paradoxical increase in energy expenditure
(Bewick et al., 2009). Bewick et al. proposed that the differences
between their model and the Reed et al. mouse model could be
due to differential peripheral vs. central nervous system ghrelin
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concentrations (Bewick et al., 2009). Of note, results regarding
the existence, sites of production and physiological significance
of endogenous central ghrelin production in non-genetically-
manipulated models have been inconsistent (Furness et al., 2011),
although ghrelin from the periphery does make its way to the
central nervous system.
After GOAT was identified, Kirchner et al. generated a double-
transgenic mouse model overexpressing both human ghrelin and
MBOAT4 (the membrane-bound O-acyltransferase domain con-
taining 4 or human variant of GOAT) genes in the liver via
the human apo-lipoprotein E promoter (Kirchner et al., 2009).
These transgenic mice, which exhibited elevated concentrations
of human ghrelin only when fed on a diet containing medium-
chain triglycerides, showed decreased energy expenditure and
increased rate of body weight gain without changes in food intake
(Kirchner et al., 2009).
Other unique techniques have been employed to increase
ghrelin expression. Yamada and colleagues generated transgenic
mice overexpressing a ghrelin analog, which replaced Ser3 with
Trp3, under the control of human serum amyloid-P promoter
(Yamada et al., 2010). Trp3-ghrelin possesses lower levels of
ghrelin-like activity without the need for post-transcriptional
modification (Matsumoto et al., 2001). Although mice overex-
pressing Trp3-ghrelin displayed a ∼6-fold increase of ghrelin-like
activity, neither body weight, food intake, energy expenditure or
fat mass differed from wild-type controls (Ariyasu et al., 2012).
Our group generated transgenic mice that express the immortal-
izing SV40 large T-antigen in ghrelin cells (Zhao et al., 2010b).
These mice develop ghrelin-secreting tumors, which result in
∼25-fold higher plasma ghrelin concentrations and ∼37-fold
higher plasma desacyl-ghrelin levels by the time they reach 20
weeks of age (Zhao et al., 2010b). Despite the sustained increase in
plasma ghrelin levels, food intake and body weights in these trans-
genic mice were indistinguishable from those in wild-type mice;
older transgenic mice lost weight, presumably due to the develop-
ment of large gastric tumors (Zhao et al., 2010b). Iwakura et al.
also created ghrelin promoter SV40 large T-antigen transgenic
mice (Iwakura et al., 2009). These mice showed no difference in
body weights as compared to wild-type mice before 12 weeks of
age, after which body weight and food intake declined, likely due
to tumor growth (Iwakura et al., 2009).
HOMEOSTATIC EATING IN MICE WITH GHRELIN DEFICIENCY
To our knowledge, four different ghrelin knockout mouse mod-
els have been reported (Sun et al., 2003; Wortley et al., 2004; De
Smet et al., 2006; Dezaki et al., 2006). Regardless of the complete
absence of ghrelin in circulation in these models, under ad libitum
standard rodent chow diet (CHD) feeding, food intake and body
weights in these ghrelin knockout mice were indistinguishable
from those in wild-type mice. In addition, no differences were
observed when other parameters of food intake were measured,
including post-fasting hyperphagia (Sun et al., 2003; Wortley
et al., 2004; Pfluger et al., 2008), forced dark cycle-induced eat-
ing (De Smet et al., 2006) or eating memory (Sato et al., 2008).
These findings suggest that genetic ghrelin deficiencies fail to
cause significant alterations in homeostatic aspects of eating
behaviors.
Furthermore, three of the four ghrelin knockout models have
been studied under chronic high fat diet (HFD) feeding, but
yielded inconsistent results (Wortley et al., 2005; Dezaki et al.,
2006; Sun et al., 2008). Surprisingly, none of the studies exhibited
the expected reduction of HFD intake. Wortley et al. did demon-
strate that ghrelin deficiency resulted in reduced body weight and
fat mass, but these results were not recapitulated in the other
mouse ghrelin knockout mouse models. Differences in the age
at which the mice were first exposed to HFD diet are thought
to account for the inconsistencies in the body weight phenotype
among the different ghrelin knockout models. In particular, resis-
tance to the development of diet-induced obesity may manifest in
ghrelin knockout mice upon early exposure to HFD, but not when
HFD challenge is initiated later in life (Wortley et al., 2004, 2005;
Sun et al., 2008).
HOMEOSTATIC EATING IN MICE WITH GHSR DEFICIENCY
To our knowledge, three different mouse models with GHSR
deficiency have been reported in the literature (Sun et al., 2004;
Zigman et al., 2005; Abizaid et al., 2006). Two are traditional
GHSR knockout models, in which the GHSR gene has been
removed (Sun et al., 2004; Abizaid et al., 2006), and the other is
a GHSR-null model in which the GHSR locus has been modified
by the insertion of a loxP-flanked transcriptional blocking cas-
sette (Zigman et al., 2005). More specifically, this transcriptional
blocking cassette sequence disrupts GHSR gene expression and,
as a consequence, the GHSR-null mice (harboring 2 copies of the
recombinant GHSR allele) have no detectable functional GHSR
expression. Cre recombinase mediates reactivation of GHSR gene
expression by removal of the transcriptional blocking cassette
sequence.
GHSR-deficient mice show a subtle but significant decrease
in body weight. Sun et al. reported that GHSR knockout mice
fed on CHD show a lower body weight than wild-type mice
from 16 to 24 weeks of age (Sun et al., 2004). GHSR-deficient
mice do not differ from wild-type controls in food intake under
CHD (Sun et al., 2004; Zigman et al., 2005). Sun et al. found
that GHSR knockout mice have a similar susceptibility to diet-
induced obesity compared to wild-type mice upon exposure to
HFD as adults (Sun et al., 2008); however, GHSR knockout mice
manifest reduced age-associated obesity mainly due to reduced
adiposity and increased thermogenesis (Lin et al., 2011; Ma et al.,
2011). Using a restrictive eating paradigm, Abizaid et al. showed
that GHSR knockout mice did not increase their food intake in
response to repeated fasts as seen in wild-type mice. This was also
true in ghrelin knockout mice (Abizaid et al., 2006).
In the GHSR-null mice from our group, female GHSR-null
mice on CHD were significantly lighter than wild-type controls
starting at 12 weeks of age (Zigman et al., 2005). Also, in two inde-
pendent studies, GHSR-null mice were resistant to HFD-induced
body weight gain upon early HFD exposure (Zigman et al., 2005;
Perello et al., 2012).
As previously mentioned, in animals, a preprandial rise in
ghrelin occurs simultaneously or possibly precedes the increased
locomotion exhibited in anticipation of a scheduledmeal (Drazen
et al., 2006). In preliminary studies, Gooley et al. examined
food-entrainable circadian rhythms in a very small cohort of
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female GHSR-null mice (Gooley et al., 2006). Similar to wild-type
littermates, the GHSR-null mice continued to show a prepran-
dial rise in locomotor activity and body temperature, suggesting
that intact ghrelin signaling was not required for the expres-
sion of food-entrainable circadian rhythms that are likely related
to finding food (Gooley et al., 2006). Furthermore, Blum et al.
also demonstrated increased activity prior to scheduled meal-
time in both wild-type and GHSR knockout mice, although in
their study, the response in GHSR knockout mice was atten-
uated (Blum et al., 2009). Others have also similarly reported
that GHSR knockout mice under a restricted feeding paradigm
demonstrate attenuated anticipatory locomotor responses and
reduced expression of themarker of cellular activation c-fos in the
mesolimbic dopamine pathway (Blum et al., 2009; Lamont et al.,
2012). Using a different paradigm, Verhagen et al. have shown
that GHSR knockout mice did not anticipate food when exposed
to an activity-based anorexia model, in which mice are given free
access to a running wheel and fed once per day for 2 h (Verhagen
et al., 2011). Thus, most of these studies suggest that a disrup-
tion in the ghrelin signaling results in the lack of food anticipation
behavior.
HOMEOSTATIC EATING IN MICE WITH BOTH GHRELIN AND GHSR
DEFICIENCY
In another study, significant differences in body weight
(decreased), energy expenditure (increased) and locomotor activ-
ity (increased) were observed when both ghrelin and GHSR were
deficient in mice (double knockout mice), whereas neither ghre-
lin deficiency nor GHSR deficiency independently affected energy
balance under CHD feeding conditions (Pfluger et al., 2008).
Thus, the authors speculated that additional components of the
ghrelin signaling system might be present.
HOMEOSTATIC EATING IN MICE WITH TISSUE-SPECIFIC GHSR
EXPRESSION
The GHSR-null mouse model with Cre recombinase-dependent
reactivation of GHSR has been valuable in establishing the phys-
iological roles of certain of ghrelin’s brain targets (Zigman et al.,
2005). In one study, we have used GHSR-null mice to assess the
role of direct action of ghrelin on the ventral tegmental area
(VTA) and other catecholaminergic neurons. We achieved this by
crossing GHSR-null mice with mice containing Cre recombinase
expression driven by the tyrosine hydroxylase (TH) promoter,
resulting in mice expressing GHSR selectively in TH-containing
cells normally programmed to express this receptor (Chuang
et al., 2011). This selective GHSR expression did not affect body
weight, but partially restored ghrelin-stimulated food intake to
levels achievable in wild-type littermates (Chuang et al., 2011). In
another study, we crossed GHSR-null mice with mice containing
expression driven by the paired-like homeobox 2b (Phox2b) pro-
moter, resulting in mice expressing GHSR selectively in specific
hindbrain nuclei, including the nucleus of the solitary tract, dor-
somotor nucleus of the vagus, area postrema, nucleus ambiguus
and facial motor nucleus (Scott et al., 2012). In contrast to
mice with catecholaminergic neuron-selective GHSR expression,
mice with hindbrain-selective GHSR expression lacked ghrelin-
induced acute food intake (Scott et al., 2012). Thus, as opposed to
GHSR-expressing catecholaminergic neurons, GHSR-expressing
hindbrain neurons are not sufficient to mediate the acute orexi-
genic effects of ghrelin.
HOMEOSTATIC EATING IN MICE WITH GHSR OVER EXPRESSION IN
GROWTH HORMONE RELEASING HORMONE NEURONS
Lall et al. generated a mouse model overexpressing GHSR in GH
releasing hormone (GHRH) neurons using a rat GHRH cosmid
promoter (GHRH-GHSR) (Lall et al., 2004). GHRH-GHSR mice
had an increased post-weaning growth rate compared to wild-
type littermates. When placed on HFD at 2 months of age, weight
gain of GHRH-GHSR mice was similar to that of their wild-type
counterparts, although fat pad mass trended lower. Food intake
was not measured for individually-housed mice, however groups
of GHRH-GHSR mice ate significantly more calories when fed
HFD than when fed CHD, while groups of wild-type mice ate
similar caloric amounts of HFD and CHD (Lall et al., 2004).
HOMEOSTATIC EATING IN MICE WITH GOAT DEFICIENCY
Two GOAT knockout mouse lines have been reported (Gutierrez
et al., 2008; Zhao et al., 2010a). Using one of these lines, GOAT
knockout mice demonstrated higher levels of desacyl-ghrelin
compared to their wild-type littermates, and under CHD feed-
ing had normal body weight and fat mass (Kirchner et al., 2009).
However, when fed HFD, these GOAT knockout mice displayed
significantly lower body weights compared to wild-type ani-
mals, despite not having significant changes in body composition.
Challenging GOAT knockout mice with HFD rich in medium-
chain triglycerides significantly reduced body weight and fat mass
compared to similarly-treated wild-type littermates (Kirchner
et al., 2009). Such was likely due to increased energy expendi-
ture, since food intake in the GOAT knockout mice was higher
(Kirchner et al., 2009). In contrast, the GOAT knockout mice
generated by Zhao et al. had similar body weight, body compo-
sition and food intake as wild-type littermates, both on CHD and
HFD (Zhao et al., 2010a). They also demonstrated similar weight
loss curves when subjected to a severe caloric restriction protocol
(Zhao et al., 2010a).
HOMEOSTATIC EATING IN MICE WITH DEFICIENCIES IN GHRELIN
SIGNALING AND LEPTIN
Ghrelin and leptin are both regulators of feeding, but have oppo-
site effects on food intake. Unlike ghrelin, leptin increases with
positive energy balance and inhibits food intake. Furthermore,
leptin- and ghrelin-responsive central targets partially overlap
(Zigman and Elmquist, 2003; Perello et al., 2012). To investi-
gate the physiological roles of ghrelin and leptin signaling, and
their potential interaction in regulating energy balance, Sun et al.
crossed ghrelin knockout mice with leptin deficient (ob/ob) mice
to generate mice lacking both ghrelin and leptin (ghrelin knock-
out ob/ob). Although they predicted that the ghrelin knockout
ob/ob mice would have a leaner and relatively hypophagic phe-
notype, the double knockout mice instead displayed similar food
intake and a modest increase in body weight as compared to
ob/ob mice (Sun et al., 2006). Ma and colleagues generated mice
with GHSR deletion on the ob/ob background (GHSR knockout
ob/ob) (Ma et al., 2012). They found that food intake and body
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weights of GHSR knockout ob/ob mice were similar to those of
ob/ob mice, possibly suggesting that the obesity in ob/ob mice is
unrelated to unopposed ghrelin action.
GHRELIN AND HEDONIC EATING
Hedonic eating is defined as food intake motivated primarily
by pleasure. Hedonic eating also encompasses behaviors aimed
at facilitating access to pleasurable food. Ghrelin is thought to
increase the rewarding value of palatable foods. Recent studies
show that ghrelin is able to regulate different aspects of hedo-
nic eating. The two-food choice test is a conventional behavioral
method for determining preference. In this test, rodents are
offered a pair of different types of food simultaneously, and the
consumed amount is measured for a defined time. Using this test,
it has been shown that ghrelin administration shifts food pref-
erence toward diets rich in fat (Shimbara et al., 2004). Ghrelin
administration also increases intake of palatable saccharin solu-
tion and preference for saccharin-flavored foods in mice (Disse
et al., 2010). Similarly, rats treated with a GHSR antagonist con-
sume less peanut butter and Ensure®, but do not change intake of
CHD in a free choice protocol (Egecioglu et al., 2010). As will be
discussed below, ghrelin administration also affects other mod-
els of hedonic eating, including the conditioned place preference
(CPP) test and operant responding.
The central distribution of GHSRs within mesolimbic cen-
ters supports the likelihood of ghrelin playing a major role
in hedonic eating. In particular, GHSR is highly expressed in
dopaminergic VTA neurons, which project to the nucleus accum-
bens (NAc) and strongly drive reward behaviors (Perello and
Zigman, 2012). Mesolimbic circuitries also may be indirectly
regulated by cholinergic neurons located in the laterodorsal
tegmental area (LDTg), which express GHSR and innervate
the VTA (Dickson et al., 2010). In addition, we have recently
shown that ghrelin action on food reward requires intact
orexin signaling, although the neuronal circuits linking orexin
neurons and ghrelin action remain unclear (Perello et al.,
2010).
HEDONIC EATING IN MICE WITH GENETIC DELETION OF GHSR
The use of mouse models deficient in GHSR have been instru-
mental in demonstrating an obligatory role for intact ghrelin
signaling in various hedonic aspects of eating. Egecioglu et al.
showed that GHSR knockout mice have a suppressed intake
of the rewarding food in a free choice (CHD/rewarding food)
paradigm and a reduced accumbal dopamine release induced by
rewarding foods (Egecioglu et al., 2010). We recently subjected
GHSR-null mice to a cue-potentiated feeding protocol, in which
cue-potentiated feeding was demonstrated by enhanced intake
of grain-based pellets selectively upon presentation of a positive
conditioned stimulus (Walker et al., 2012). While wild-type mice
demonstrated cue-potentiated feeding behavior, GHSR-null mice
lacked this behavior. More specifically, GHSR-null mice displayed
enhanced food intake in response to both positive and negative
conditioned stimuli (Walker et al., 2012). This study supports
pharmacologic studies suggesting a key role for intact ghrelin
signaling pathways in establishing a specific positive cue-food
association (Kanoski et al., 2013).
Altered eating behaviors are observed under stress as well
as depression. In order to study the role of ghrelin in stress-
associated hedonic eating, our group subjected both GHSR-null
and wild-type littermates to a mouse behavioral model of chronic
psychosocial stress andmajor depression, known as chronic social
defeat stress (CSDS). Mice were challenged with ten daily bouts
of social defeat by aggressive CD1 male mice, a protocol which
results in an increase in plasma ghrelin (Lutter et al., 2008).
Despite an increase in plasma ghrelin levels, GHSR-null mice
failed to increase intake of CHD in response to chronic stress,
unlike wild-type controls which increased their food intake. This
suggests that activation of GHSR signaling is required for a
stress-induced increase in caloric intake. In addition, stressed
GHSR-null and wild-type mice were also tested in a food CPP
test, which models a more complex, reward-related type of eat-
ing behavior. In the food CPP test, animals are conditioned to
associate one chamber of the CPP apparatus with CHD and a
second, visually and texturally distinct chamber with an equal
calorie amount of a more pleasurable food, such as HFD. After
conditioning, animals are given free access to both chambers in
the absence of the food, and CPP is demonstrated when more
time is spent in the chamber previously paired to the food reward.
The CSDS-CPP protocol seems to model stress-based comfort
food eating. Following exposure to the CSDS protocol, GHSR-
null mice did not demonstrate CPP for HFD, whereas wild-type
mice did (Chuang et al., 2011).
The above findings in GHSR-null mice confirm pharmaco-
logical studies; as administration of ghrelin and other means of
achieving increases in plasma ghrelin (caloric restriction) both
enable acquisition of food CPP (Perello et al., 2010; Disse et al.,
2011), while administration of GHSR antagonists blocks food
CPP (Egecioglu et al., 2010; Perello et al., 2010). Likewise, in
our studies using mice subjected to a caloric restriction in which
mice were limited to 80% of their usual daily food intake, GHSR-
null mice did not demonstrate CPP for HFD, whereas wild-type
mice did (Perello et al., 2010). Interestingly, when the study was
repeated inmice exposed to amore intense calorie restriction pro-
tocol, in which mice were limited to ad libitum access to CHD for
4 h per day, no differences between genotypes were detected in the
food CPP test. Thus, endogenous increases in GHSR signaling fol-
lowing stress as modeled with the CSDS protocol or under mild
food restrictive conditions enable acquisition of CPP for HFD
(Perello et al., 2010).
HEDONIC EATING IN MICE WITH TISSUE-SPECIFIC REACTIVATION OF
GHSR
We also assessed food CPP performance following CSDS or as
induced by administered ghrelin in mice with catecholaminer-
gic selective GHSR expression, using the mice described above in
section Homeostatic Eating in Mice with Tissue Specific GHSR
Expression (Chuang et al., 2011). Such selective GHSR expres-
sion in TH-expressing cells was sufficient to mediate the ability of
administered ghrelin or chronic stress to induce CPP for HFD.
HEDONIC EATING IN MICE WITH GOAT DEFICIENCY
Recently, it was determined that GOAT-mediated acylation of
ghrelin is a critical modulator of food reward. Following a
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24-h food deprivation period, GOAT-deficient mice displayed
an attenuated motivation for food in an operant responding
model (Davis et al., 2012). This supports several pharmacologic
studies in which ghrelin administration increased operant lever
pressing for sucrose, peanut butter-flavored sucrose or HFD pel-
lets in rodents, and in which GHSR antagonist reduced operant
responding for sucrose solution (Perello et al., 2010; Finger et al.,
2012; Landgren et al., 2012; Skibicka et al., 2012). GOAT knock-
out mice also showed a decreased hedonic feeding response as
examined in a “dessert effect” protocol, wherein the intake of
a palatable HFD “dessert” was assessed in calorically-sated mice
(Davis et al., 2012). Furthermore, GOAT knockout mice displayed
atypical transcriptional changes in orexin 1 receptor gene expres-
sion in the NAc, potentially implying the involvement of orexin
signaling in these effects of ghrelin (Davis et al., 2012). Taken
together, these results suggest that the motivation to obtain food
is regulated by endogenous GOAT activity.
DISCUSSION
In this review, we have summarized the findings of ghrelin action
on eating behavior as determined or confirmed using different
mouse models with genetic manipulations of the ghrelin signal-
ing system. Of note, the various transgenic mouse models more
consistently demonstrated alterations in hedonic eating, while
changes to homeostatic eating and body weight changes were
more variable and subtle.
An important consideration when evaluating the eating-
related phenotypes of the various transgenic models relates to
differences between manipulations of ghrelin vs. GHSR vs. GOAT.
For example, variable degrees of altered homeostatic eating,
hedonic eating and body weight have been observed in ghrelin-
deficient, GHSR-deficient, and GOAT-deficient models. Although
the exact reasons for these differences are unclear, they could
result from differences inherent to each of those molecules. For
instance, GHSR possesses strong ligand-independent constitu-
tive activity when studied in vitro (Holst et al., 2004; Holst and
Schwartz, 2004), and thus phenotypic changes in GHSR-null mice
could result from the combined loss of ghrelin binding and of
baseline GHSR “tone.” Additionally, it has been proposed that
ghrelin has other receptors besides GHSR, which could explain
why simultaneous deletion of both ghrelin and GHSR result in a
more severe phenotype than deletion of either alone (Holst et al.,
2004; Pfluger et al., 2008). Furthermore, GOAT may have other
substrates besides ghrelin, and thus its loss could directly affect
more than just ghrelin bioactivity.
Another concern when evaluating these mouse models, as with
any transgenic mouse models, is the possibility of functional
redundancy or developmental compensation by another related
system, which may mask the true effect of manipulation of the
ghrelin system. While this has not yet been demonstrated specifi-
cally for the ghrelin system, it has been demonstrated for AgRP
neurons that are thought to be crucial for ghrelin’s effects on
eating. Importantly, unlike the lack of significant body weight
or food intake phenotypes in mice with genetic AgRP abla-
tion achieved since inception or in neonates, rapid starvation
ensues when AgRP expression is deleted in adult mice (Qian
et al., 2002; Gropp et al., 2005; Luquet et al., 2005). Such a
time-dependent effect of genetic AgRP deletion may be influ-
enced by a time-sensitive capacity for the development of com-
pensatory neurocircuits (Bouret et al., 2004; Luquet et al., 2005).
Indeed, leptin’s neurotrophic effects on hypothalamic develop-
ment are restricted to a critical neonatal period (Bouret et al.,
2004). Similar time-sensitive neurotrophic actions have been
predicted for ghrelin (Steculorum and Bouret, 2011).
Further considerations when evaluating the effects of genetic
engineering—in particular, those changes induced in standard
transgenic models in which the transgene is randomly inserted
into the genome—include the potential for the site of integration
to affect tissue specificity, levels of transgene expression as well as
expression of other genes present in the nearby genomic vicinity.
For all these reasons, the use of the multiple mouse models gen-
erated using different genetic strategies and comparison of these
mice to mice treated pharmacologically with agents targeting the
ghrelin system is important for best determining the importance
of the ghrelin system in eating behavior
It should also be noted that these various genetically-
engineered mouse models targeting the ghrelin system addition-
ally have been used to assess the importance of ghrelin action
in domains other than those related to eating and body weight.
For instance, GHSR-null mice have been used to demonstrate a
key role for ghrelin action in minimizing depressive-like behav-
ior following chronic stress (Lutter et al., 2008). Also, ghrelin-
overexpressing, ghrelin-knockout, GHSR-knockout, GHSR-null
and GOAT-knockout mice all demonstrate alterations in glu-
cose homeostasis, with the most extreme phenotype—namely
marked hypoglycemia and near death—appearing upon severe
caloric restriction of mice with genetic deletion of either GOAT
or ghrelin (Zhao et al., 2010a; Li et al., 2012).
These studies predict eating- and body weight-related phe-
notypes for people if they were to carry a genetic mutation
engendering either ghrelin and/or GOAT overexpression or ghre-
lin, GHSR or GOAT deletion. Indeed, the extreme hyperphagia,
early-onset obesity and debilitating food seeking behaviors asso-
ciated with Prader-Willi Syndrome, in which ghrelin levels are
found to elevated and abnormally regulated, represent much
more extreme phenotypes than the mouse models of ghrelin
over expression would predict (Feigerlova et al., 2008; Hinton
et al., 2010). As of yet, no definitive examples of ghrelin, GHSR
or GOAT deletion have been identified in people. However,
other types of mutations—in the ghrelin gene and the GHSR
gene—have been identified. One, the Leu72Met ghrelin poly-
morphism has been associated with binge eating disorder in
small cohorts (Monteleone et al., 2007). Several GHSR poly-
morphisms have been found in individuals with short stature,
which makes sense given ghrelin’s ability to potently stimulate
GH secretion. Using in vitro methods, these mutations result in
loss of endogenous constitutive activity of GHSR, altered bind-
ing of ghrelin, decreased ghrelin-stimulated signal transduction,
and/or decrease cell surface expression of GHSR (Wang et al.,
2004; Pantel et al., 2006; Inoue et al., 2011). Interestingly, carri-
ers of some of these GHSRmutations demonstrate an incomplete
penetrance of overweight and obesity, although the relationship
of the mutation and the body weight phenotypes have not been
confirmed (Wang et al., 2004).
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Given the crucial insight regarding ghrelin action on feed-
ing and other domains provided by these mouse models, we
would encourage further investigations using not only the cur-
rently available mouse models, but also novel genetically modi-
fied mouse models. For instance, a GHSR-conditional knockout
mouse in which GHSR is eliminated exclusively from a single cell
type or a single brain region by using the Cre-loxP technology is
an exciting alternative. Additionally, the Cre-loxP system could be
used to investigate the role of GHSR at specific stages of devel-
opment by breeding GHSR floxed mouse lines with transgenic
mice bearing a tamoxifen-dependent Cre recombinase expressed
under the control of specific promoters, thus allowing the manip-
ulation of GHSR to be controlled in a spatiotemporal-specific
manner. In addition, mouse models containing some of the
above-described ghrelin and GHSR polymorphisms described in
individuals with binge eating disorder and families with short
stature± overweight/obesity would help clarify and causative role
for the mutations in those conditions.
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